Standout Papers
Citation Impact
Citing Papers
Mapping the Antigenic and Genetic Evolution of Influenza Virus
2004 StandoutScience
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Influence of Antibiotic Therapy on Mortality of Critical Surgical Illness Caused or Complicated by Infection
2005
Duration of Antibiotic Therapy for Ventilator-Associated Pneumonia Caused by Non-Fermentative Gram-Negative Bacilli
2007
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
2012
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
2012
Post–Acute Care Use and Hospital Readmission after Sepsis
2015
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
1986 StandoutNobel
The safety of targeted antibiotic therapy for ventilator-associated pneumonia: A multicenter observational study
2008
The Infectivity ofCryptosporidium parvumin Healthy Volunteers
1995 Standout
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Cystic Fibrosis Pulmonary Guidelines
2009
Vulvovaginal candidosis
2007 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
De-Escalation Therapy: Is It Valuable for the Management of Ventilator-Associated Pneumonia?
2011
De-escalation in lower respiratory tract infections
2006
General Principles of Antimicrobial Therapy
2011
Cystic fibrosis
2016 Standout
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
2007
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit*
2008
Use of Quantitative Cultures and Reduced Duration of Antibiotic Regimens for Patients with Ventilator-Associated Pneumonia to Decrease Resistance in the Intensive Care Unit
2006
Severe Sepsis and Septic Shock
2013 Standout
Short- vs Long-Duration Antibiotic Regimens for Ventilator-Associated Pneumonia
2013
Antibiotic Utilization and Outcomes for Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative BAL Culture Results
2005
Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs
1991
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Most CD4+ T cells from human immunodeficiency virus-1 infected patients can undergo prolonged clonal expansion.
1989 StandoutNobel
Global Burden of Tuberculosis
1999 Standout
Mortality, Attributable Mortality, and Clinical Events as End Points for Clinical Trials of Ventilator‐Associated Pneumonia and Hospital‐Acquired Pneumonia
2010
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Sepsis and septic shock
2018 Standout
Rates and dates of divergence between AIDS virus nucleotide sequences.
1988
Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy
1992 Standout
Contribution of Blinded, Protected Quantitative Specimens to the Diagnostic and Therapeutic Management of Ventilator-Associated Pneumonia
2005
Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study
2008
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment
2012
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
1993 Standout
Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
2009
Subthreshold Quantitative Bronchoalveolar Lavage: Clinical and Therapeutic Implications
2008
Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study
2009
Airway Mucus Function and Dysfunction
2010 Standout
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate
2007
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Diagnosis of ventilator-associated pneumonia
2013
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
AIDS and tuberculosis in Spain. A report of 140 cases
1991
Variation in critical care services across North America and Western Europe*
2008
Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study
2009
A Massive Outbreak in Milwaukee of Cryptosporidium Infection Transmitted through the Public Water Supply
1994 Standout
De-escalation therapy in ventilator-associated pneumonia*
2004
Development of a Guideline for the Management of Ventilator-Associated Pneumonia Based on Local Microbiologic Findings and Impact of the Guideline on Antimicrobial Use Practices
2008
Natural history of acquired immunodeficiency syndrome in women in rhode island
1989
Tuberculosis and HIV infection in sub-Saharan Africa
1992
Human Immunodeficiency Virus Infection among Men with Sexually Transmitted Diseases
1988 Standout
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
1989 Standout
Durée de l’antibiothérapie lors du traitement des pneumopathies acquises sous ventilation mécanique : comparaison entre sept jours et dix jours. Étude pilote
2008
Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients
2007
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
Early Antibiotic Discontinuation in Patients With Clinically Suspected Ventilator-Associated Pneumonia and Negative Quantitative Bronchoscopy Cultures*
2013
Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: Diagnosis and treatment
2008
Procalcitonin Kinetics as a Prognostic Marker of Ventilator-associated Pneumonia
2004
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS
1984 Science
Prevalence of Antibodies to Lymphadenopathy-Associated Retrovirus in African Patients with AIDS
1984 StandoutScienceNobel
The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.
1987 StandoutNobel
The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection
1986 StandoutScience
Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults
2015
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
1986 StandoutNobel
AIDS virus env Protein Expressed from a Recombinant Vaccinia Virus
1986 StandoutNobel
Genome organization and transactivation of the human immunodeficiency virus type 2
1987 StandoutNatureNobel
THE AIDS PROBLEM IN AFRICA
1986
Antibodies to the Core Protein of Lymphadenopathy-Associated Virus (LAV) in Patients with AIDS
1984 StandoutScienceNobel
Human Immunodeficiency Virus Type 2 Infection Associated with AIDS in West Africa
1987 StandoutNobel
Human Immunodeficiency Viruses
1986 StandoutScienceNobel
Mycobacterial Disease: Epidemiology, Diagnosis, Treatment, and Prevention
1988
A History of HIV Discovery
2002 StandoutScienceNobel
HTLV-III in Saliva of People with AIDS-Related Complex and Healthy Homosexual Men at Risk for AIDS
1984 Science
A Randomized Controlled Trial of an Antibiotic Discontinuation Policy for Clinically Suspected Ventilator-Associated Pneumonia
2004
Isolation of a New Human Retrovirus from West African Patients with AIDS
1986 StandoutScienceNobel
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Lymphadenopathy-Associated-Virus Infection and Acquired Immunodeficiency Syndrome
1986 StandoutNobel
Timing the Ancestor of the HIV-1 Pandemic Strains
2000 Science
Pathology of Mycobacterium aviumintracellulare infection in acquired immunodeficiency syndrome
1987
The acquired immune deficiency syndrome.
1984
Tuberculosis and the Acquired Immunodeficiency Syndrome at a New York City Hospital: 1978-1985
1987
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
1984
Molecular cloning of lymphadenopathy-associated virus
1984 StandoutNatureNobel
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys.
1994 StandoutNobel
HTLV-I-SPECIFIC ANTIBODY IN AIDS PATIENTS AND OTHERS AT RISK
1984
Neurologic Complications in Acquired Immunodeficiency Syndrome (AIDS)
1984
The chronology of AIDS research
1987 StandoutNatureNobel
The Epidemiology of AIDS: Current Status and Future Prospects
1985 Science
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
Isolation of Lymphadenopathy-Associated Virus (LAV) and Detection of LAV Antibodies From US Patients With AIDS
1985 StandoutNobel
High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states.
1985
Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF and review of the literature
1985
ACQUIRED IMMUNODEFICIENCY SYNDROME IN A HETEROSEXUAL POPULATION IN ZAIRE
1984
Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon.
1985
Lymphadenopathy-Associated Viral Antibody in AIDS
1984 StandoutNobel
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
1986 StandoutScience
Cryptosporidiosis associated with traveling and giardiasis
1985
Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia
2013
Mycobacterium aviumComplex Infection in the Acquired Immunodeficiency Syndrome
1991 Standout
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Complete nucleotide sequence of the AIDS virus, HTLV-III
1985 StandoutNature
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa
2007
Works of Franck Thomas being referenced
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Characteristics of the Acquired Immunodeficiency Syndrome (AIDS) in Haiti
1983